InvestorsHub Logo
Followers 137
Posts 5060
Boards Moderated 0
Alias Born 01/31/2012

Re: nyy13 post# 81186

Monday, 04/10/2017 6:12:45 PM

Monday, April 10, 2017 6:12:45 PM

Post# of 203912
LOL. If people sell because of lack of revs on the 10K -- they're dumb to begin with. Everybody with a brain knows there was little to no revenue to report in 2016.

Yes, I certainly always tried to accompany my PPS guesses due to reasoning.

The fact that we ran to $3.23 on February 23rd was kind of stupid. What happened? They announced they were going to a conference that we all knew about for at least a month. Oh, and, we were listed on the pending AgroSphere ETF. Maybe that was the driving factor since CNBX ran big time that same day and they too were included.

So, if we can run to $3.23 for something like that... But can't run to $3.23+ after we announce a possible partnership with Big Pharma, phenomenal study results, a new Executive (formery from Big Pharma), and a new/big distribution deal... (Who knows what's all coming)... Why NOT $3.23+ again?

I've said before... AstraZeneca sold their SUICIDE PROVOKING Psoriasis drug for $445 MILLION in 2015. If OWCP proves to have a better product with little to no side effects... Why can't our market cap reach $500,000,000?

That's ~$3.33/share.